Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noel W. Lawson is active.

Publication


Featured researches published by Noel W. Lawson.


Anesthesia & Analgesia | 1974

The use of hemodilution and fresh autologous blood in open-heart surgery.

Noel W. Lawson; John L. Ochsner; Noel L. Mills; George L. Leonard

Three hundred patients were randomly selected and comprised two statistically balanced groups of 150 each. Group I received fresh autologous transfusions following extracorpeal circulation and homologous whole bank blood when further blood replacement was necessary. Group II served as controls, receiving whole bank blood following extracorporeal circulation and again when further blood replacement was necessary. Both groups were hemodiluted during bypass. The total amount of whole bank blood required during the hospital stay in group I was significantly less than in group II.There was no significant change in the preoperative and postoperative determinations of partial thromboplastin time, clotting time or prothrombin time in group I patients. These same time tests were increased in group II patients but were not clinically significant, attesting to the efficacy of a relatively brief period of extracorporeal circulation. Platelet counts and fibrinogen levels decreased during cardiopulmonary bypass in group I patients but increased immediately with reinfusion of the fresh autologous blood.An improved technic of hemospasia is described which reduces the demand for bank blood by roughly 50 percent.


Anesthesia & Analgesia | 1983

Neuromuscular and electrocardiographic responses to verapamil in dogs.

Noel W. Lawson; Barry J. Kraynack; Jonas Gintautas

Because severe muscular weakness was noted in animals receiving verapamil in doses exceeding those used in humans, we studied the effects of verapamil on neuromuscular function and its correlation with myocardial conduction. The flexor carpi radialis and its nerves were surgically exposed in mechanically ventilated dogs during pentobarbital anesthesia. Indirect and direct electrical stimulation was applied and twitch height recorded following the intravenous administration of verapamil. Twenty animals received one of four dose schedules. The results showed a significant dose-related depression of twitch height to indirect stimulation. Twitch height to direct stimulation was reduced only zuith the highest dose. The onset of depression of indirect stimulation was temporally associated with onset of A-V conduction delay. However, recovery following indirect stimulation lagged behind recovery of the ECG by 30 min. Recovery times of twitch height following indirect stimulation ranged from 60–208 min and also were dose-related. The qualitative similarity of pancuronium and verapamil on indirect twitch height suggests a similar site of action, i.e., the neuromuscular junction. A presynaptic or postsynaptic effect of verapamil could not be discerned in this study. Verapamil may produce an unrecognized source of weakness in the anesthetized patient either alone or through interaction With anesthetic agents or adjuncts.


Anesthesia & Analgesia | 1983

Effects of Verapamil on Indirect Muscle Twitch Responses

Barry J. Kraynack; Noel W. Lawson; Jonas Gintautas; Hon Tjoenj Tjay

The effects on indirectly elicited muscle twitch amplitude associated with the calcium (slow) channel blocker, verapamil, with or without pancuronium were investigated using isolated bullfrog sciatic nerve-sartorius muscle preparations. Verapamil (2–8 mM) produced a dose-related depression of indirect muscle twitch height (P < 0.05). Twitch response was depressed 11% below control by the lowest concentration employed and 86% by the highest concentration. Pancuronium (0.07 mM) depressed neuromus- cular function 35% below control (P < 0.05). The combination of 5 mM or 8 mM verapamil with 0.07 mM pancuronium caused significantly greater degrees of depression than either drug alone. Verapamil produced significant depression of twitch height in vitro in relatively high concentrations. The mechanism of action remains unknown. Verapamil possesses pharmacologic properties that may be unrelated to slow (calcium) channel inhibition. The reduction of muscle twitch height caused by verapamil alone (5 mM) could not be antagonized by neostigmine, calcium, or frequent washings.


Anesthesia & Analgesia | 1976

Sodium nitroprusside-induced hypotension for supine total hip replacement.

Noel W. Lawson; Dola S. Thompson; Carl L. Nelson; Joan W. Flacke; Edward R. North

Deliberate hypotension was produced during general anesthesia by the infusion of sodium nitroprusside in 13 patients undergoing total hip replacement. Hernodynamic data from these patients were compared with those obtained from 5 patients under normotensive anesthesia for the same procedure. During the hypotensive period, which averaged 1.5 hours, the cardiac index rose 20 percent compared with controls. No acidotic tendency was seen. Blood loss in the study group averaged 475 ml, compared with 1475 ml in controls. From these data, a dose-response curve was derived which may allow the accurate prediction of the minute dosage of sodium nitroprusside required to safely induce hypotension during anesthesia.


American Journal of Surgery | 1979

Reappraisal of intravenous procaine as a short-acting anesthetic adjuvant

Dola S. Thompson; Astride B. Seifen; Alfredo A. Ferrari; Noel W. Lawson

Our data in 74 patients demonstrate that procaine hydrochloride is a safe anesthetic adjuvant in doses of 1 mg/kg/min even when total doses are 5 to 7 g. Blood pressure, heart rate, electrocardiographic variables, and blood gases were not adversely affected. Patients had no nausea or untoward postanesthesia symptoms. Emergence from anesthesia was rapid, within less than 15 minutes in all patients, and most were fully awake before leaving the operating room. In two patients in whom blood levels were studied the drug disappeared within 40 minutes. Procaine is inexpensive,


Anesthesia & Analgesia | 1976

A dosage nomogram for sodium nitroprusside-induced hypotension under anesthesia.

Noel W. Lawson; Dola S. Thompson; Carl L. Nelson; Joan W. Flacke; Astride B. Seifen

1.16 for 10 g, and it is not a known liver or kidney toxin. Until studies on cardiovascular dynamics and analgesic effects as in whom a low plasma cholinesterase activity is present or suspected. The clinical appraisal in 56 patients indicates its usefulness in suppressing premature venticular contractions and cough reflexes during endoscopic procedures in the respiratory tract. Procaine can be used to advantage in supplementing general anesthesia in outpatient surgery because of its brief action. For these reasons, the drug merits further study.


Survey of Anesthesiology | 1979

Intravenous Procaine as a Supplement to General Anesthesia for Carbon Dioxide Laser Resection of Laryngeal Papillomas in Children

Noel W. Lawson; Douglas Rogers; Astride B. Seifen; Allen White; Dola S. Thompson

Sodium nitroprusside (SNP) was used to produce deliberate hypotension in 30 selected patients, 9 to 78 years of age, for total hip replacement under halothane-N2O-O2anesthesia. Hypotension was induced in the first 13 patients by infusing a 0.01% (100 μg/ml) solution of nitroprusside (NP) in 5% dextrose. Blood pressure was diminished to a level just producing a dry surgical field. Preliminary data demonstrated that the mean arterial blood pressure (MAP) achieving this condition was 65 torr (p< 0.01) and that the minute dosage of NP (μg/min) required to consistently reduce MAP to 65 torr could not be predicted on the basis of body weight.However, the age/weight ratio (yr/kg) of each patient, plotted against the known minute dosage of NP given during anesthesia, produced a highly significant dose-response curve (P<0.001, r = −0.8226).The preliminary dose-response curve was examined in a double-blind study on an additional 17 patients. The curve derived from the prospective study did not differ from that of the preliminary study. In addition, the combined data from the retrospective and prospective studies (30 patients) gave a better statistical fit than did those from the preliminary study alone (p<0.001, r = −0.8939).The nomogram provides an additional margin of safety in the use of this potent, fast-acting drug. SNP has been found predictable and effective in reducing surgical blood loss in selected patients undergoing total hip replacement.


Survey of Anesthesiology | 1979

Intravenous Procaine for General Anesthesia in Dogs: A New Look at an Old Technic

D. S. Thompson; R. H. Smith; Noel W. Lawson

Procaine suppresses the cough reflex, decreases laryngeal irritability, and has general anesthetic properties. For these reasons, 14 pediatric patients undergoing CO2 laser resection of laryngeal papillomas were studied in which an intravenous infusion of procaine (1 mg/kg/min) was added to N2O-O2 halothane/enflurane general anesthesia immediately following endotracheal intubation. These patients were compared to nine patients receiving the same anesthesia without procaine.The mean age of both groups was 11 years. There was no difference between the groups in duration of anesthesia or surgery. Emergence, however, averaged 15 minutes in study patients compared to 36 minutes in the control group (p<0.01). There was no difference in anesthetic concentrations required to maintain satisfactory operative conditions in the two groups. Muscle relaxants were required intraoperatively in seven control patients but in none of the study patients. The surgeon ranked the operative conditions excellent in all study patients but poor in seven of the nine control patients. Five of the latter required postoperative treatment of laryngeal complications, including reintubation in three. Only one of the study patients had postoperative stridor. No evidence of procaine toxicity was noted in the study patients with total doses ranging from 500–3600 mg. Intravenous procaine is useful in pediatric patients having endoscopic laryngeal operations.


Annals of Surgery | 1973

Fresh autologous blood transfusions with extracorporeal circulation.

John L. Ochsner; Noel L. Mills; George L. Leonard; Noel W. Lawson

ABSTRACT: New anesthetics have been introduced during the last 25 years which are not without inherent disadvantages. They are expensive, and some produce nephrotoxicity and possibly hepatotoxicity. Although the use of procaine intravenously as an anesthetic has been discarded, probably because of a convulsive effect, it is believed this disadvantage can be controlled by concomitant use of other drugs. Hence procaine, preceded by thiamylal, was administered to dogs to test its anesthetic capability, reversibility, and effects on the cardiovascular and central nervous systems. Blood levels of procaine were measured and correlated with these physiologic responses. Convulsive doses were ten times those producing anesthesia. There were no detrimental effects which would preclude a reevaluation in humans. Intravenous procaine produces definite general anesthesia, and it has the additional advantages of being rapidly hydrolyzed and providing antiarrhythmic effects. It may prove useful in modern anesthesia.


Anesthesia & Analgesia | 1979

Intravenous procaine as a supplement to general anesthesia for carbon dioxide laser resection for carbon dioxide laser resection of laryngeal papillomas in children.

Noel W. Lawson; Rogers D; Astride B. Seifen; White A; Dola S. Thompson

Collaboration


Dive into the Noel W. Lawson's collaboration.

Top Co-Authors

Avatar

Dola S. Thompson

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Astride B. Seifen

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Barry J. Kraynack

Texas Tech University Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

Jonas Gintautas

Texas Tech University Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alfredo A. Ferrari

University of Arkansas for Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge